Both in Biotechnology
Estrella Immunopharma vs Black Hawk Acquisition
Over the past year ESLA returned −82.7% and BKHA returned −50.3%; their daily moves had a correlation of 0.03.
ESLA −82.7% BKHA −50.3%Growth of $1, one year, split-adjusted
| Metric | ESLA | BKHA |
|---|---|---|
| Price | $0.4435 | $5.57 |
| Market cap | $19.3M | $23.1M |
| Today | +6.10% | −0.18% |
| 1 month | +3.4% | −54.6% |
| 6 months | −65.9% | — |
| Year to date | −71.6% | −50.5% |
| 1 year | −85.5% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $146.7K | — |
| Dividend yield | — | — |
| Volatility (60d) | 201.6% | 159.2% |
| Short % of float | 4.0% | 2.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).